中国药房2016，Vol.27Issue(21)：2898-2900,3.DOI:10.6039/j.issn.1001-0408.2016.21.06
醒脑静注射液对急性脑梗死血瘀证患者疗效及相关指标的影响Δ
Effect of Xingnaojing Injection on the Efficacy and Safety of Patients with Acute Cerebral Infarction Merge Blood Stasis Syndrome
摘要
Abstract
OBJECTIVE:To observe the effects of Xingnaojing injection on the efficacy and safety of patients with acute cere-bral infarction merge blood stasis syndrome. METHODS:70 patients with acute cerebral infarction merge blood stasis syndrome were randomly divided into observation group(35 cases)and control group(35 cases). Control group received conventional treat-ment according to 2014 edition of Chinese guideline for diagnosis and management of acute ischemic stooke. Patients within throm-bolysis time window were given intravenaus infusion of rt-PA,and those out of thrombolysis time window orally received 0.3 g As-pirin tablet every evening,then 0.1 g after 1 week+40 mg Atorvastatin calcium tablet every evening,and if patients have arfficulty suallowing,gavage administiation was implemented. Observation group additionally received 30 ml Xingnaojing injection,adding in-to 250 ml 0.9% Sodium chloride injection,intravenous infusion,once a day. The treatment course for both groups was 14 d. Clini-cal efficacy,γ-interferon(IFN-γ),interleukin-13(IL-13),interleukin-4(IL-4),high-sensitivity C-reactive protein(hs-CRP)lev-els,the US National Institutes of Health Stroke Scale(NIHSS)rating,improved Barthel index(BI),infarction size before and af-ter treatment and the incidence of adverse reactions in 2 groups were observed. RESULTS:There was no significant difference in the total effective rate and incidence of adverse reactions in 2 groups(P>0.05). Before treatment,there were no significant differ-ences in IFN-γ,IL-13,IL-4,hs-CRP levels,the NIHSS rating,BI and infarction size in 2 groups(P>0.05). After treatment,the IFN-γ,hs-CRP levels,the NIHSS rating and infarction size in 2 groups were significantly lower than before,and observation group was lower than control group,IL-13,IL-4 and BI were significantly higher than before,and observation group was higher than control group,the differences were statistically significant (P<0.05 or P<0.01). CONCLUSIONS:Based on conventional treatment,Xingnaojing injection shows obvious efficacy the efficacy and safety of patients with acute cerebral infarction merge blood stasis syndrome,it can reduce the levels of inflammatory cytokines,improve neurological deficits,daily living skills and in-farct volume,with good safety.关键词
醒脑静注射液/急性脑梗死/血瘀证/炎症因子/疗效/安全性Key words
Xingnaojing injection/Acute cerebral infarction/Blood stasis syndrome/Inflammatory cytokines/Efficacy/Safety分类
医药卫生引用本文复制引用
卢志刚,刘芸..醒脑静注射液对急性脑梗死血瘀证患者疗效及相关指标的影响Δ[J].中国药房,2016,27(21):2898-2900,3.基金项目
湖北省教育厅科学研究计划项目（No.Q20144303）；荆门市科技计划重点项目（No.荆科计〔2014〕7号）；荆楚理工学院校级科研基金项目 （）
